Facial Rhytides
11
0
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
55%
6 trials in Phase 3/4
90%
9 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (11)
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A
A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
Reliability of the Facial Wrinkle Scale in Japanese Subjects